{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T09:26:55Z","timestamp":1793698015174,"version":"4.5.1"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Curtin University","id":[{"id":"https:\/\/ror.org\/02n415q13","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Curtin University","id":[{"id":"https:\/\/ror.org\/02n415q13","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Pharmacists are integral to vaccination strategies globally and within Australia\u2019s National Immunisation Program. However, limited evidence exists regarding how uptake of pharmacist-administered vaccination varies across demographic groups and geographic locations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>This study aimed to analyse trends and patterns in pharmacist-administered vaccinations delivered within a predominantly Western Australian community pharmacy network.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>A retrospective descriptive analysis was undertaken using de-identified routine vaccination records from January 2021 to April 2025. Data were sourced from a booking system (January 2021\u2013March 2024) and a clinical record system (April 2024\u2013April 2025) of a selected pharmacy group. Temporal trends and vaccination patterns, stratified by demographic (age and sex) and geographical distributions, including Modified Monash Model (MMM) category and proximity to medical centres, were assessed. Vaccination rates per 100, 000 population were calculated across age, sex, and MMM groups using Western Australian vaccination records as the numerator and corresponding population estimates as the denominator.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Over 1.1 million vaccination records spanning 19 vaccine types were analysed. COVID-19 vaccines accounted for 59.4% of all vaccinations, peaking between late 2021 and early 2022. Influenza vaccination showed consistent seasonal peaks (March\u2013June), with a decline in 2024 compared with previous years. Administration of other routine vaccines was variable but gradually increased, particularly in 2024. Vaccination rate per 100,000 population was highly variable among age groups, with an overall lower vaccination rate among younger individuals (aged 5\u201319\u00a0years) and older people (aged \u226585\u00a0years). Vaccination services were concentrated in metropolitan areas and pharmacies near medical centres, with a similar pattern between males and females.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Community pharmacists played a vital role in vaccination delivery, particularly during the COVID-19 pandemic and seasonal influenza periods. Routine vaccine administration has the potential to expand further with targeted health campaigns to improve public awareness and uptake across all populations and regions. Further research should develop strategies to enhance equitable access across geographic areas.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11096-026-02221-0","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:58:57Z","timestamp":1789477137000},"page":"2440-2455","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Trends and patterns of pharmacist-administered vaccination in a predominantly Western Australian pharmacy group: retrospective analysis of routinely collected data"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5982-853X","authenticated-orcid":false,"given":"Ashenafi Kibret","family":"Sendekie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7212-0667","authenticated-orcid":false,"given":"Petra","family":"Czarniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0068-5006","authenticated-orcid":false,"given":"Tin Fei","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneika","family":"Tonkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2477-2190","authenticated-orcid":false,"given":"Leanne","family":"Chalmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"2221_CR1","unstructured":"World Health Organization. Vaccines and immunization. Avaialble at https:\/\/www.who.int\/health-topics\/vaccines-and-immunization#tab=tab_1. Accessed on 18 Mar 2025."},{"issue":"10441","key":"2221_CR2","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1016\/s0140-6736(24)00850-x","volume":"403","author":"AJ Shattock","year":"2024","unstructured":"Shattock AJ, Johnson HC, Sim SY, et al. Contribution of vaccination to improved survival and health: modelling 50 years of the Expanded Programme on Immunization. Lancet. 2024;403(10441):2307\u201316. https:\/\/doi.org\/10.1016\/s0140-6736(24)00850-x.","journal-title":"Lancet"},{"issue":"5","key":"2221_CR3","doi-asserted-by":"publisher","first-page":"378","DOI":"10.2500\/aap.2021.42.210065","volume":"42","author":"LD Frenkel","year":"2021","unstructured":"Frenkel LD. The global burden of vaccine-preventable infectious diseases in children less than 5 years of age: Implications for COVID-19 vaccination. How can we do better? Allergy Asthma Proc. 2021;42(5):378\u201385. https:\/\/doi.org\/10.2500\/aap.2021.42.210065.","journal-title":"Allergy Asthma Proc"},{"issue":"10500","key":"2221_CR4","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/s0140-6736(25)01037-2","volume":"406","author":"GBD 2023 Vaccine Coverage Collaborators","year":"2025","unstructured":"GBD 2023 Vaccine Coverage Collaborators. Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global Burden of Disease Study 2023. Lancet. 2025;406(10500):235\u201360. https:\/\/doi.org\/10.1016\/s0140-6736(25)01037-2.","journal-title":"Lancet"},{"issue":"1","key":"2221_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-025-23754-5","volume":"25","author":"U U\u011frak","year":"2025","unstructured":"U\u011frak U, Aksungur A, Aky\u00fcz S, et al. Understanding the rise of vaccine refusal: perceptions, fears, and influences. BMC Public Health. 2025;25(1):2574. https:\/\/doi.org\/10.1186\/s12889-025-23754-5.","journal-title":"BMC Public Health"},{"issue":"5","key":"2221_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13050529","volume":"13","author":"GH Shah","year":"2025","unstructured":"Shah GH, Nguyen TH. Vaccine hesitancy through a global lens: cross-cultural evidence from a special issue. Vaccines (Basel). 2025;13(5):529. https:\/\/doi.org\/10.3390\/vaccines13050529.","journal-title":"Vaccines (Basel)"},{"issue":"8","key":"2221_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13080806","volume":"13","author":"LN Al-Eitan","year":"2025","unstructured":"Al-Eitan LN, Almahdawi DL, Abu Khiarah RA, et al. Bridging gaps in vaccine access and equity: a Middle Eastern perspective. Vaccines. 2025;13(8):806. https:\/\/doi.org\/10.3390\/vaccines13080806.","journal-title":"Vaccines"},{"issue":"Suppl 1","key":"2221_CR8","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.vaccine.2022.02.073","volume":"42","author":"KL O'Brien","year":"2030","unstructured":"O\u2019Brien KL, Lemango E, Nandy R, et al. The immunization Agenda 2030: a vision of global impact, reaching all, grounded in the realities of a changing world. Vaccine. 2030;42(Suppl 1):S1\u20134. https:\/\/doi.org\/10.1016\/j.vaccine.2022.02.073.","journal-title":"Vaccine"},{"key":"2221_CR9","unstructured":"FIP\u2014International Pharmaceutical Federation. Vaccine administration and prescribing by pharmacists: Scope of services, training, and impact. Available at https:\/\/prevention.fip.org\/wp-content\/uploads\/2024\/12\/Vaccines-administration-and-prescribing.pdf. Accessed on 20 Nov 2025."},{"issue":"40","key":"2221_CR10","doi-asserted-by":"publisher","first-page":"5939","DOI":"10.1016\/j.vaccine.2019.08.060","volume":"37","author":"A Poudel","year":"2019","unstructured":"Poudel A, Lau ETL, Deldot M, et al. Pharmacist role in vaccination: evidence and challenges. Vaccine. 2019;37(40):5939\u201345. https:\/\/doi.org\/10.1016\/j.vaccine.2019.08.060.","journal-title":"Vaccine"},{"key":"2221_CR11","doi-asserted-by":"publisher","first-page":"1152556","DOI":"10.3389\/fpubh.2023.1152556","volume":"11","author":"MS Romero-Mancilla","year":"2023","unstructured":"Romero-Mancilla MS, Mora-Vargas J, Ruiz A. Pharmacy-based immunization: a systematic review. Front Public Health. 2023;11:1152556. https:\/\/doi.org\/10.3389\/fpubh.2023.1152556.","journal-title":"Front Public Health"},{"issue":"1","key":"2221_CR12","doi-asserted-by":"publisher","DOI":"10.1080\/20523211.2023.2285955","volume":"17","author":"MHA Rahim","year":"2023","unstructured":"Rahim MHA, Dom SHM, Hamzah MSR, et al. Impact of pharmacist interventions on immunisation uptake: a systematic review and meta-analysis. J Pharm Policy Pract. 2023;17(1):2285955. https:\/\/doi.org\/10.1080\/20523211.2023.2285955.","journal-title":"J Pharm Policy Pract"},{"issue":"5","key":"2221_CR13","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1016\/j.japh.2022.06.008","volume":"62","author":"LM Le","year":"2003","unstructured":"Le LM, Veettil SK, Donaldson D, et al. The impact of pharmacist involvement on immunization uptake and other outcomes: an updated systematic review and meta-analysis. J Am Pharm Assoc (2003). 2003;62(5):1499-1513.e16. https:\/\/doi.org\/10.1016\/j.japh.2022.06.008.","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"7","key":"2221_CR14","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.sapharm.2025.03.004","volume":"21","author":"Y Elghanam","year":"2025","unstructured":"Elghanam Y, Kim EY. Impact of pharmacist intervention on enhancing vaccination coverage: a systematic review and meta-analysis. Res Social Adm Pharm. 2025;21(7):495\u2013504. https:\/\/doi.org\/10.1016\/j.sapharm.2025.03.004.","journal-title":"Res Social Adm Pharm"},{"issue":"6","key":"2221_CR15","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2023.2583","volume":"4","author":"C Layson-Wolf","year":"2023","unstructured":"Layson-Wolf C, Sharfstein JM. US community pharmacies and public health\u2014building on the COVID-19 response. JAMA Health Forum. 2023;4(6):e232583. https:\/\/doi.org\/10.1001\/jamahealthforum.2023.2583.","journal-title":"JAMA Health Forum"},{"issue":"3","key":"2221_CR16","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1177\/0897190020980626","volume":"35","author":"K Hess","year":"2022","unstructured":"Hess K, Bach A, Won K, et al. Community pharmacists roles during the COVID-19 pandemic. J Pharm Pract. 2022;35(3):469\u201376. https:\/\/doi.org\/10.1177\/0897190020980626.","journal-title":"J Pharm Pract"},{"issue":"46","key":"2221_CR17","doi-asserted-by":"publisher","first-page":"7054","DOI":"10.1016\/j.vaccine.2018.09.040","volume":"36","author":"SM Bartsch","year":"2018","unstructured":"Bartsch SM, Taitel MS, DePasse JV, et al. Epidemiologic and economic impact of pharmacies as vaccination locations during an influenza epidemic. Vaccine. 2018;36(46):7054\u201363. https:\/\/doi.org\/10.1016\/j.vaccine.2018.09.040.","journal-title":"Vaccine"},{"key":"2221_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.pharma.2016.08.005","volume":"75","author":"CL Kirkdale","year":"2017","unstructured":"Kirkdale CL, Nebout G, Megerlin F, et al. Benefits of pharmacist-led flu vaccination services in community pharmacy. Ann Pharm Fr. 2017;75:3\u20138. https:\/\/doi.org\/10.1016\/j.pharma.2016.08.005.","journal-title":"Ann Pharm Fr"},{"issue":"9","key":"2221_CR19","doi-asserted-by":"publisher","first-page":"372","DOI":"10.4140\/tcp.n.2020.372","volume":"35","author":"A Poudel","year":"2020","unstructured":"Poudel A, Lau ET, Campbell C, et al. Unleashing our potential\u2014pharmacists\u2019 role in vaccination and public health. Sr Care Pharm. 2020;35(9):372\u20138. https:\/\/doi.org\/10.4140\/tcp.n.2020.372.","journal-title":"Sr Care Pharm"},{"key":"2221_CR20","doi-asserted-by":"publisher","first-page":"237437352413094","DOI":"10.1177\/23743735241309473","volume":"12","author":"U Religioni","year":"2025","unstructured":"Religioni U, Vaillancourt R, Kazmierczak J, et al. Patient opinions and satisfaction regarding pharmacists delivering vaccinations in community pharmacies. J Patient Exp. 2025;12:23743735241309470. https:\/\/doi.org\/10.1177\/23743735241309473.","journal-title":"J Patient Exp"},{"key":"2221_CR21","doi-asserted-by":"publisher","unstructured":"Sendekie AK, Czarniak P, Chalmers, et al. Pharmacist-administered vaccinations for children and adolescents in Australia: a review of policies, legislation and lessons learnt. Public Health Res Pract. 2026;36(2):PU25042. https:\/\/doi.org\/10.1071\/pu25042.","DOI":"10.1071\/pu25042"},{"issue":"4","key":"2221_CR22","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3390\/pharmacy14040092","volume":"14","author":"SN Amare","year":"2026","unstructured":"Amare SN, Choon Yee K, Leung M, et al. The evolution of pharmacist administered vaccinations in Australia: a narrative review of legislation and regulatory documents. Pharmacy. 2026;14(4):92. https:\/\/doi.org\/10.3390\/pharmacy14040092.","journal-title":"Pharmacy"},{"key":"2221_CR23","unstructured":"Nissen L, Glass B, Lau E, et al. Queensland pharmacist immunisation pilot phase 1 pharmacist vaccination-Influenza final report. Available at https:\/\/eprints.qut.edu.au\/91903\/. Accessed on 20 Mar 2024."},{"key":"2221_CR24","doi-asserted-by":"publisher","unstructured":"Patel C, Vette K, Dalton L, et al. Assessment of the first 5 years of pharmacist-administered vaccinations in Australia: learnings to inform expansion of services. Public Health Res Pract. 2024;34(3):e3432420. https:\/\/doi.org\/10.17061\/phrp3432420.","DOI":"10.17061\/phrp3432420"},{"key":"2221_CR25","unstructured":"Vette K, Dalton L, Dey A, et al. National Centre for Immunisation Research and Surveillance. Review of pharmacist vaccination reporting to the Australian Immunisation Register. Final report\u2014Parts A and B May 2020. Available at https:\/\/ncirs.org.au\/sites\/default\/files\/2020-06\/Review%20of%20pharmacist%20vaccination%20reporting%20to%20the%20AIR_Final%20report_May%202020.pdf. Accessed on 18 Mar 2025."},{"key":"2221_CR26","unstructured":"Mart S. Vaccination: pharmacy board of Australia 2013. Available at http:\/\/ www.pharmacyboard.gov.au\/News\/Newsletters\/March-2014. aspx#vaccination. Accessed 0n 20 Mar 2024."},{"key":"2221_CR27","unstructured":"National Centre for Immunisation Research and Surveillance. Annual Immunisation Coverage Report 2021. Available at https:\/\/ncirs.org.au\/sites\/default\/files\/2022-12\/NCIRS%20Annual%20Immunisation%20Coverage%20Report%202021_FINAL.pdf. Accessed on 11 Dec 2024."},{"key":"2221_CR28","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1071\/MA24055","volume":"45","author":"B Hart","year":"2024","unstructured":"Hart B. The evolving role of Australian community pharmacists in vaccination: challenges and opportunities. Microbiol Aust. 2024;45:201\u20134. https:\/\/doi.org\/10.1071\/MA24055.","journal-title":"Microbiol Aust"},{"key":"2221_CR29","unstructured":"Pharmacy Programs Administrator. National Immunisation Program Vaccinations in Pharmacy (NIPVIP) Program. Available at https:\/\/www.ppaonline.com.au\/programs\/national-immunisation-program-vaccinations-in-pharmacy-program. Accessed on 18 Mar 2025."},{"issue":"3","key":"2221_CR30","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1093\/ijpp\/riad014","volume":"31","author":"TNT Bui","year":"2023","unstructured":"Bui TNT, Janetzki JL, Chai WC, et al. Exploring consumers\u2019 perspective of community pharmacists delivering COVID-19 vaccinations: an Australian pilot study. Int J Pharm Pract. 2023;31(3):337\u201340. https:\/\/doi.org\/10.1093\/ijpp\/riad014.","journal-title":"Int J Pharm Pract"},{"issue":"10","key":"2221_CR31","doi-asserted-by":"publisher","first-page":"3782","DOI":"10.1016\/j.sapharm.2022.04.008","volume":"18","author":"K Chiu","year":"2022","unstructured":"Chiu K, Thow AM, Bero L. The tension between national consistency and jurisdictional professional expansion: the case of pharmacist-administered vaccinations. Res Social Adm Pharm. 2022;18(10):3782\u201391. https:\/\/doi.org\/10.1016\/j.sapharm.2022.04.008.","journal-title":"Res Social Adm Pharm"},{"issue":"3","key":"2221_CR32","doi-asserted-by":"publisher","DOI":"10.17061\/phrp3432420","volume":"34","author":"C Patel","year":"2024","unstructured":"Patel C, Vette K, Dalton L, et al. Assessment of the first 5 years of pharmacist-administered vaccinations in Australia: learnings to inform expansion of services. Public Health Res Pract. 2024;34(3):e3432420.","journal-title":"Public Health Res Pract"},{"key":"2221_CR33","unstructured":"Pharmacy 777. Available at https:\/\/www.pharmacy777.com.au\/about-us\/777-story. Accessed on 18 Mar 2025."},{"key":"2221_CR34","unstructured":"Pharmacy 777. Health Services |In-Pharmacy Vaccinations. Available at https:\/\/www.pharmacy777.com.au\/our-services\/vaccinations. Accessed on 18 Mar 2025."},{"key":"2221_CR35","unstructured":"Modified Monash Model (MMM) Suburb and Locality Classification\u2014Home Care Subsidy. Available at https:\/\/www.health.gov.au\/resources\/publications\/modified-monash-model-mmm-suburb-and-locality-classification-home-care-subsidy?language=en. Accessed on 17 Jun 2025."},{"key":"2221_CR36","unstructured":"Centers for Disease Control and Prevention. Principles of epidemiology in public health practice. 3rd ed. Atlanta (GA): U.S. Department of Health and Human Services; 2012. Available at https:\/\/archive.cdc.gov\/www_cdc_gov\/csels\/dsepd\/ss1978\/SS1978.pdf. Accessed on 19 May 2026."},{"key":"2221_CR37","unstructured":"Australian Institute of Health and Welfare. Statistical terms explained [Internet]; 2023. Available at https:\/\/www.aihw.gov.au\/getmedia\/314083b4-dee7-4f7c-960d-198d60606093\/aihw-fact-sheet_statistical-terms-explained-oct-2023.pdf. Accessed on 21 May 2026."},{"key":"2221_CR38","unstructured":"Australian Bureau of Statistics. Regional population by age and sex, 2024. Available at https:\/\/www.abs.gov.au\/statistics\/people\/population\/regional-population-age-and-sex\/latest-release. Accessed on 20 May 2026."},{"key":"2221_CR39","unstructured":"Australian Department of Health, Disability and Ageing. Modified Monash Model. Available at https:\/\/www.health.gov.au\/topics\/rural-health-workforce\/classifications\/mmm. Accessed 20 May 2026."},{"key":"2221_CR40","unstructured":"National Centre for Immunisation Research and Surveillance (NCIRS) Australia. Annual Immunisation Coverage Report, 2022. Available at https:\/\/ncirs.org.au\/sites\/default\/files\/2024-01\/NCIRS%20Annual%20immunisation%20coverage%20report%202022.pdf. Accessed on 18 Mar 2025."},{"issue":"1","key":"2221_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2024.102305","volume":"65","author":"R El Kalach","year":"2003","unstructured":"El Kalach R, Jones-Jack NH, Grabenstein JD, et al. Pharmacists\u2019 answer to the COVID-19 pandemic: contribution of the Federal Retail Pharmacy Program to COVID-19 vaccination across sociodemographic characteristics-United States. J Am Pharm Assoc. 2003;65(1):102305. https:\/\/doi.org\/10.1016\/j.japh.2024.102305.","journal-title":"J Am Pharm Assoc"},{"issue":"6","key":"2221_CR42","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/j.japh.2022.08.010","volume":"62","author":"JD Grabenstein","year":"2022","unstructured":"Grabenstein JD. Essential services: quantifying the contributions of America\u2019s pharmacists in COVID-19 clinical interventions. J Am Pharm Assoc. 2022;62(6):1929-1945.e1. https:\/\/doi.org\/10.1016\/j.japh.2022.08.010.","journal-title":"J Am Pharm Assoc"},{"issue":"1","key":"2221_CR43","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2024.2388938","volume":"20","author":"M Yang","year":"2024","unstructured":"Yang M, Ma W, Jiang J, et al. COVID-19 vaccination and concerns regarding vaccine hesitancy after the termination of the zero-COVID policy in China: a nationwide cross-sectional study. Hum Vaccin Immunother. 2024;20(1):2388938. https:\/\/doi.org\/10.1080\/21645515.2024.2388938.","journal-title":"Hum Vaccin Immunother"},{"key":"2221_CR44","unstructured":"CDC: Centers for Disease Control and Prevention. COVID-19 Vaccination Trends in the United States, National and Jurisdictional. Available at https:\/\/data.cdc.gov\/Vaccinations\/COVID-19-Vaccination-Trends-in-the-United-States-N\/rh2h-3yt2\/about_data. Accessed on 18 Mar 2025."},{"key":"2221_CR45","unstructured":"European Centre for Disease Prevention and Control. COVID-19 vaccination. Available at https:\/\/www.ecdc.europa.eu\/en\/covid-19\/prevention-and-control\/vaccines. Accessed on 18 Mar 2025."},{"issue":"15","key":"2221_CR46","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1016\/j.vaccine.2023.03.002","volume":"41","author":"SO AlMahasis","year":"2023","unstructured":"AlMahasis SO, Fox B, Ha D, et al. Pharmacy-based immunization in rural USA during the COVID-19 pandemic: a survey of community pharmacists from five southeastern states. Vaccine. 2023;41(15):2503\u201313. https:\/\/doi.org\/10.1016\/j.vaccine.2023.03.002.","journal-title":"Vaccine"},{"key":"2221_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.rcsop.2024.100447","volume":"14","author":"M Haems","year":"2024","unstructured":"Haems M, Lanzilotto M, Mandelli A, et al. European community pharmacists practice in tackling influenza. Explor Res Clin Soc Pharm. 2024;14:100447. https:\/\/doi.org\/10.1016\/j.rcsop.2024.100447.","journal-title":"Explor Res Clin Soc Pharm"},{"key":"2221_CR48","unstructured":"National Centre for Immunisation Research and Surveillance (NCIRS) Australia. Influenza vaccination coverage data. Available at https:\/\/ncirs.org.au\/influenza-vaccination-coverage-data. Accessed on 18 Mar 2025."},{"issue":"7","key":"2221_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0004756","volume":"5","author":"H Melchinger","year":"2020","unstructured":"Melchinger H, Belgaumi SM, Ahmed N, et al. Change in influenza vaccine uptake among adults in the United States from May 2020 to October 2024. PLoS Glob Public Health. 2020;5(7):e0004756. https:\/\/doi.org\/10.1371\/journal.pgph.0004756.","journal-title":"PLoS Glob Public Health"},{"key":"2221_CR50","unstructured":"Australian Government. Department of Health, Disability and Ageing. Immunisation dashboards. Available at https:\/\/www.health.gov.au\/topics\/immunisation\/immunisation-dashboards. Accessed on 04 Aug 2026."},{"issue":"1","key":"2221_CR51","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2026.2655516","volume":"22","author":"A Dirks","year":"2026","unstructured":"Dirks A, Do H, Ford M, et al. Quantifying vaccine dissemination for uptake comparisons between vaccines. Hum Vaccin Immunother. 2026;22(1):2655516. https:\/\/doi.org\/10.1080\/21645515.2026.2655516.","journal-title":"Hum Vaccin Immunother"},{"key":"2221_CR52","doi-asserted-by":"publisher","unstructured":"Turner D, Woloszko N, Chalaux T, et al. Understanding differences in vaccination uptake among OECD countries, OECD Economics Department Working Papers, 2022; No. 1704, OECD Publishing, Paris, https:\/\/doi.org\/10.1787\/76482043-en.","DOI":"10.1787\/76482043-en"},{"key":"2221_CR53","unstructured":"School-based immunisation program. Available at https:\/\/www.health.wa.gov.au\/Articles\/S_T\/School-based-vaccination-program. Accessed on 28 Nov 2025."},{"key":"2221_CR54","unstructured":"Australian Government\/Department of Health, Disability, and Ageing. Supplies of the Shingrix vaccine. Available at https:\/\/www.health.gov.au\/news\/supplies-of-the-shingrix-vaccine?language=en. Accessed: 02 Sept 2025."},{"key":"2221_CR55","unstructured":"International Pharmaceutical Federation. Advancing Pharmacy Worldwide. Advocating pharmacy-based vaccination: Using FIP data and compelling evidence to achieve change at the country level. Available at https:\/\/prevention.fip.org\/wp-content\/uploads\/2024\/10\/ADVOCATING-PHARMACY-BASED-VACCINATION-1.pdf. Accessed on 02 Mar 2026."},{"issue":"1","key":"2221_CR56","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1080\/14760584.2024.2441255","volume":"24","author":"Y Zheng","year":"2018","unstructured":"Zheng Y, Wang D, Chen YT, et al. Trends in adolescent and adult vaccination in pharmacy and medical settings in the United States, 2018-2024: a database study. Expert Rev Vaccines. 2018;24(1):53\u201366. https:\/\/doi.org\/10.1080\/14760584.2024.2441255.","journal-title":"Expert Rev Vaccines"},{"key":"2221_CR57","unstructured":"Structured Administration and Supply Arrangement (SASA). Available: at https:\/\/www.health.wa.gov.au\/~\/media\/Corp\/Documents\/Health-for\/Medicines-and-Poisons\/Word\/SASA-Administration-Vaccines-Pharmacists.docx. Accessed on 02 Mar 2026."},{"key":"2221_CR58","unstructured":"Pharmaceutical Society of Australia. Pharmacist-led vaccinations. Available at https:\/\/www.psa.org.au\/state-vaccination-regulations\/. Accessed on 02 Mar 2025."},{"issue":"5","key":"2221_CR59","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1080\/21645515.2015.1127490","volume":"12","author":"JE Isenor","year":"2016","unstructured":"Isenor JE, Alia TA, Killen JL, et al. Impact of pharmacists as immunizers on influenza vaccination coverage in Nova Scotia, Canada. Hum Vaccin Immunother. 2016;12(5):1225\u20138. https:\/\/doi.org\/10.1080\/21645515.2015.1127490.","journal-title":"Hum Vaccin Immunother"},{"key":"2221_CR60","unstructured":"The University of Sydney. Vaccination rates among Australian teens are dropping. Here\u2019s how we can get back on track. Available: https:\/\/www.sydney.edu.au\/news-opinion\/news\/2024\/12\/13\/vaccination-rates-among-australian-teens-are-dropping--here-s-ho.html. Accessed on 02 Mar 2026."},{"issue":"4","key":"2221_CR61","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/1753-6405.13094","volume":"45","author":"MJ Trent","year":"2021","unstructured":"Trent MJ, Salmon DA, MacIntyre CR. Pharmacy, workplace or primary care? Where Australian adults get their influenza vaccines. Aust N Z J Public Health. 2021;45(4):385\u201390. https:\/\/doi.org\/10.1111\/1753-6405.13094.","journal-title":"Aust N Z J Public Health"},{"key":"2221_CR62","unstructured":"Australian Pharmacist Inspiring Excellence, Advancing Practice. Top tips for reaching undervaccinated groups. Available at https:\/\/www.australianpharmacist.com.au\/top-tips-for-reaching-undervaccinated-groups\/. Accessed on 02 Sept 2025."},{"issue":"3","key":"2221_CR63","doi-asserted-by":"publisher","first-page":"e126","DOI":"10.1016\/s2666-7568(22)00036-8","volume":"3","author":"GP Vigezzi","year":"2022","unstructured":"Vigezzi GP, Odone A. COVID-19 immunisation in older people. Lancet Healthy Longev. 2022;3(3):e126\u20137. https:\/\/doi.org\/10.1016\/s2666-7568(22)00036-8.","journal-title":"Lancet Healthy Longev"},{"issue":"11","key":"2221_CR64","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.sapharm.2025.06.110","volume":"21","author":"SN Amare","year":"2025","unstructured":"Amare SN, Yee KC, Leung M, et al. Impact of pharmacist-led interventions on COVID-19, herpes zoster, influenza, pneumococcal, and respiratory syncytial virus vaccines uptake in people aged 60 years and older: systematic review and meta-analysis. Res Social Adm Pharm. 2025;21(11):857\u201371. https:\/\/doi.org\/10.1016\/j.sapharm.2025.06.110.","journal-title":"Res Social Adm Pharm"},{"key":"2221_CR65","unstructured":"World Health Organization. Why Gender Matters: Immunization Agenda 2030. World Health Organization; 2021. Available at https:\/\/www.who.int\/publications\/i\/item\/9789240033948. Accessed on 02 Mar 2026."},{"key":"2221_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.100836","volume":"34","author":"T Dorji","year":"2021","unstructured":"Dorji T, Nopsopon T, Tamang ST, et al. Human papillomavirus vaccination uptake in low-and middle-income countries: a meta-analysis. EClinicalMedicine. 2021;34:100836. https:\/\/doi.org\/10.1016\/j.eclinm.2021.100836.","journal-title":"EClinicalMedicine"},{"issue":"6","key":"2221_CR67","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s13187-024-02516-8","volume":"39","author":"V Heimbecker","year":"2024","unstructured":"Heimbecker V, Bordini SC, Rodrigues AC, et al. Gender differences on the awareness of human papillomavirus infection and vaccination. J Cancer Educ. 2024;39(6):611\u20137. https:\/\/doi.org\/10.1007\/s13187-024-02516-8.","journal-title":"J Cancer Educ"},{"key":"2221_CR68","unstructured":"Australian Government\/Australian Institute of Health and Welfare. Rural and remote health. Available at https:\/\/www.aihw.gov.au\/reports\/rural-remote-australians\/rural-and-remote-health. Accessed on 02 Mar 2026."},{"issue":"9","key":"2221_CR69","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-011948","volume":"6","author":"HL Hattingh","year":"2016","unstructured":"Hattingh HL, Sim TF, Parsons R, et al. Evaluation of the first pharmacist-administered vaccinations in Western Australia: a mixed-methods study. BMJ Open. 2016;6(9):e011948. https:\/\/doi.org\/10.1136\/bmjopen-2016-011948.","journal-title":"BMJ Open"},{"issue":"1","key":"2221_CR70","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s43856-022-00183-8","volume":"2","author":"B Rader","year":"2022","unstructured":"Rader B, Astley CM, Sewalk K, et al. Spatial modeling of vaccine deserts as barriers to controlling SARS-CoV-2. Commun Med (Lond). 2022;2(1):141. https:\/\/doi.org\/10.1038\/s43856-022-00183-8.","journal-title":"Commun Med (Lond)"},{"issue":"5-6","key":"2221_CR71","doi-asserted-by":"publisher","first-page":"821","DOI":"10.17269\/s41997-018-0110-1","volume":"109","author":"L Wang","year":"2018","unstructured":"Wang L, Ramroop S. Geographic disparities in accessing community pharmacies among vulnerable populations in the Greater Toronto Area. Can J Public Health. 2018;109(5\u20136):821\u201332. https:\/\/doi.org\/10.17269\/s41997-018-0110-1.","journal-title":"Can J Public Health"},{"issue":"12","key":"2221_CR72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0294688","volume":"18","author":"A Sacre","year":"2023","unstructured":"Sacre A, Bambra C, Wildman JM, et al. Socioeconomic inequalities in vaccine uptake: a global umbrella review. PLoS ONE. 2023;18(12):e0294688. https:\/\/doi.org\/10.1371\/journal.pone.0294688.","journal-title":"PLoS ONE"},{"key":"2221_CR73","unstructured":"The Pharmacy Guild of Australia. Increased community pharmacy services will take pressure off GPs. Available at https:\/\/www.guild.org.au\/news-events\/news\/2025\/increased-community-pharmacy-services-will-take-pressure-off-gps. Accessed on 5 Mar 2026."},{"issue":"1","key":"2221_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/s12875-019-0912-0","volume":"20","author":"AMK Hindi","year":"2020","unstructured":"Hindi AMK, Schafheutle EI, Jacobs S. Community pharmacy integration within the primary care pathway for people with long-term conditions: a focus group study of patients\u2019, pharmacists\u2019 and GPs\u2019 experiences and expectations. BMC Fam Pract. 2020;20(1):26. https:\/\/doi.org\/10.1186\/s12875-019-0912-0.","journal-title":"BMC Fam Pract"},{"issue":"2","key":"2221_CR75","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1177\/13558196241290923","volume":"30","author":"E Owen-Boukra","year":"2025","unstructured":"Owen-Boukra E, Cai Z, Duddy C, et al. Collaborative and integrated working between general practice and community pharmacies: a realist review of what works, for whom, and in which contexts. J Health Serv Res Policy. 2025;30(2):136\u201348. https:\/\/doi.org\/10.1177\/13558196241290923.","journal-title":"J Health Serv Res Policy"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-026-02221-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-026-02221-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-026-02221-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T08:39:29Z","timestamp":1793695169000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-026-02221-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":75,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2221"],"URL":"https:\/\/doi.org\/10.1007\/s11096-026-02221-0","relation":{},"ISSN":["2210-7711"],"issn-type":[{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"assertion":[{"value":"9 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Affiliation details for the authors Anneika Tonkin and Kristian Ray have been corrected.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no relevant financial interests. However, TFS is the immediate past National President of the Pharmaceutical Society of Australia.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Human Research Ethics Committee of Curtin University (approval number: HRE2025-0194).","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}